- Home
- EW
as 08-27-2025 9:37am EST
Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter aortic valves, and transcatheter mitral and tricuspid valve technologies. The firm derives about 60% of its total sales from outside the US.
| Founded: | 1958 | Country: | United States |
| Employees: | N/A | City: | IRVINE |
| Market Cap: | 44.8B | IPO Year: | 2000 |
| Target Price: | $85.20 | AVG Volume (30 days): | 4.0M |
| Analyst Decision: | Buy | Number of Analysts: | 20 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 7.02 | EPS Growth: | 188.09 |
| 52 Week Low/High: | $64.00 - $83.00 | Next Earning Date: | 10-23-2025 |
| Revenue: | $5,685,100,000 | Revenue Growth: | 9.14% |
| Revenue Growth (this year): | 12.97% | Revenue Growth (next year): | 9.65% |
Stock Insider Trading Activity of Edwards Lifesciences Corporation (EW)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Chopra Daveen | EW | CVP, TMTT | Aug 25 '25 | Sell | $81.95 | 2,500 | $204,865.00 | 30,996 | |
| Wood Larry L | EW | Global President TAVR & Surg | Aug 18 '25 | Sell | $78.06 | 8,950 | $698,679.07 | 206,900.391 |
Latest Edwards Lifesciences Corporation News
EW Breaking Stock News: Dive into EW Ticker-Specific Updates for Smart Investing
Insider Monkey
10 hours ago
Citi Lifts Johnson & Johnson (JNJ) Price Target to $200 on MedTech Strength
PR Newswire
2 days ago
Pulnovo Medical Names Dr. Francis Duhay as Global Chief Medical Officer
Investor's Business Daily
6 days ago
Edwards Lifesciences Stock Pumps Up Its Relative Strength Rating
GlobeNewswire
6 days ago
Global Non-invasive Brain Trauma Monitoring Device Market Size/Share Worth USD 32.19 Billion by 2034 at a 8.13% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT)
MT Newswires
7 days ago
Leerink Partners Adjusts PT on Edwards Lifesciences to $85 From $84, Maintains Market Perform Rating
MT Newswires
8 days ago
Edwards Lifesciences Reports $500 Million Accelerated Share Buyback
Business Wire
8 days ago
Edwards Lifesciences Announces $500 Million Accelerated Share Repurchase
Simply Wall St.
9 days ago
Is There Now An Opportunity In Edwards Lifesciences Corporation (NYSE:EW)?
Compare EW vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "EW Edwards Lifesciences Corporation - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.